DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) announced U.S. FDA
approval of an expanded indication for Clinolipid to be used in pediatric
patients, including preterm and term neonates.
Clinolipid is Baxter's proprietary mixed oil lipid emulsion that is used to
provide calories and essential fatty acids in parenteral nutrition when oral or
enteral nutrition is not possible, insufficient or contraindicated.

Clinolipid has been available in the U.S. for adults since 2019 and is now
available for use in all ages. The company said it is available to order in the
U.S.

For More Such Health News, visit rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX